V

accine giant Sanofi Pasteur has quietly pulled the plug on its Zika vaccine project, a move that underscores how difficult it may be at this stage to develop a vaccine against the virus.

The company announced the move in a statement posted on its website at 3 p.m. Friday, pointing to a decision by a federal funding body to scale back spending on Zika-related research. Sanofi said BARDA — the Biomedical Advanced Research and Development Authority, an arm of the Department of Health and Human Services — informed the company in mid-August that it was reducing its financial assistance for Sanofi’s Zika vaccine project.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.